June 25, 2008FDA delays decision on Eli Lilly blood clot drug - CNN Money FDA delays decision on Eli Lilly blood clot drug - CNN Money
NEW YORK (Associated Press) - Eli Lilly and Co. said late Monday the Food and Drug Administration will take an extra three months to review its application for the blood thinning drug prasugrel. Lilly and its Japanese partner Daiichi Sankyo Co. are Source: money.cnn.com FDA stalls Lilly's coronary drug - CNN Money INDIANAPOLIS (AP) -- Eli Lilly and Co. said late Monday the Food and Drug Administration will take an extra three months to review its application for the blood thinning drug prasugrel. Lilly ( LLY , Fortune 500 ) and its Japanese partner Daiichi Source: money.cnn.com FDA OKs GlaxoSmithKline kids' combination vaccine - CNN Money NEW YORK (Associated Press) - GlaxoSmithKline PLC said Wednesday it won Food and Drug Administration approval for a combination vaccine to protect children against diphtheria, tetanus, pertussis and polio. Glaxo said the vaccine, Kinrix, is the first Source: money.cnn.com FDA Extends Review Period for Daiichi Sankyo, Lilly Investigative - MSN MoneyCentral Companies confirm the start of TRILOGY ACS clinical trial to study Prasugrel against Clopidogrel in medically managed ACS patients TOKYO and INDIANAPOLIS, June 23 /PRNewswire-FirstCall/ -- Daiichi Sankyo Company, Limited, 4568 and Eli Lilly and Source: news.moneycentral.msn.com FDA calls for seizure of pet food from PETCO Illinois distribution - Detroit News U.S. Marshals have seized animal food products allegedly stored under unsanitary conditions at a PETCO supplies distribution center in Joliet, Ill., U.S. Food and Drug Administration officials said in an alert Monday. Widespread rodent and bird Source: www.detnews.com FDA: Merck can’t expand market for cervical cancer vaccine - Philadelphia Inquirer NEWARK, N.J. - Drug maker Merck & Co. said today that the Food and Drug Administration has rejected expanding the use of cervical cancer vaccine Gardasil to include women age 27 to 45. The agency cited "issues that preclude approval" within the Source: www.philly.com FDA Extends Review Of Daiichi-Lilly Drug Prasugrel For 3 Months - CNN Money Daiichi Sankyo Co. (9130.TO) of Japan and Eli Lilly & Co. (LLY) said the Food and Drug Administration extended the review period three months for their anti- clotting drug prasugrel. The FDA is expected to act by Sept. 26 . Lilly's shares were at $47 Source: money.cnn.com # posted by Network @ 11:00 PM
 |
Subscribe to Posts [Atom]